Filing metadata

Accession number
0001415889-24-002378
Form type
Form 4
Filer
IRulya Therapeutics Inc.
CIK
CIK 1662774
Filed
Feb 02, 2024
Reporting period
Feb 01, 2024
Description
Insider transaction

Explore SEC Filings Hub